IN2012DN06631A - - Google Patents
Info
- Publication number
- IN2012DN06631A IN2012DN06631A IN6631DEN2012A IN2012DN06631A IN 2012DN06631 A IN2012DN06631 A IN 2012DN06631A IN 6631DEN2012 A IN6631DEN2012 A IN 6631DEN2012A IN 2012DN06631 A IN2012DN06631 A IN 2012DN06631A
- Authority
- IN
- India
- Prior art keywords
- yloxy
- methyl
- isoxazol
- pyran
- piperidin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30492110P | 2010-02-16 | 2010-02-16 | |
PCT/IB2011/050548 WO2011101774A1 (en) | 2010-02-16 | 2011-02-09 | (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN06631A true IN2012DN06631A (zh) | 2015-10-23 |
Family
ID=43904611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN6631DEN2012 IN2012DN06631A (zh) | 2010-02-16 | 2011-02-09 |
Country Status (15)
Country | Link |
---|---|
US (1) | US20120041026A1 (zh) |
EP (1) | EP2536713A1 (zh) |
JP (1) | JP2013519722A (zh) |
KR (1) | KR20120123089A (zh) |
CN (1) | CN102762554A (zh) |
AR (1) | AR080172A1 (zh) |
AU (1) | AU2011216950A1 (zh) |
CA (1) | CA2788656A1 (zh) |
IN (1) | IN2012DN06631A (zh) |
MX (1) | MX2012008721A (zh) |
SG (1) | SG183111A1 (zh) |
TW (1) | TW201141856A (zh) |
UY (1) | UY33225A (zh) |
WO (1) | WO2011101774A1 (zh) |
ZA (1) | ZA201206469B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
US10583138B2 (en) | 2012-07-12 | 2020-03-10 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
TWI537265B (zh) * | 2011-05-18 | 2016-06-11 | 拉夸里亞創藥股份有限公司 | 4-{[4-({[4-(2,2,2-三氟乙氧基)-1,2-苯並異唑-3-基]氧基}甲基)哌啶-1-基]甲基}-四氫-2h-吡喃-4-羧酸的多晶型形式 |
WO2014080633A1 (en) * | 2012-11-21 | 2014-05-30 | Raqualia Pharma Inc. | Polymorph forms |
IN2013CH01199A (zh) | 2013-03-20 | 2015-08-14 | Suven Life Sciences Ltd | |
JP6161823B2 (ja) | 2013-12-16 | 2017-07-12 | スヴェン・ライフ・サイエンシズ・リミテッド | 5−ht4受容体アゴニストとしてのインダゾール化合物 |
RU2679619C2 (ru) * | 2014-05-20 | 2019-02-12 | Раквалиа Фарма Инк. | Солевое производное бензизоксазола |
TR201909997T4 (tr) | 2015-02-13 | 2019-07-22 | Suven Life Sciences Ltd | 5-HT4 reseptör agonistleri olarak amid bileşikleri. |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2104297C (en) | 1991-02-27 | 2003-05-27 | Boyd Lynn Harrison | 4-sulfanimide-quinoline nmda antagonists |
US5750542A (en) * | 1993-09-28 | 1998-05-12 | Pfizer | Benzisoxazole and benzisothizole derivatives as cholinesterase inhibitors |
NZ243065A (en) * | 1991-06-13 | 1995-07-26 | Lundbeck & Co As H | Piperidine derivatives and pharmaceutical compositions |
CA2149918A1 (en) * | 1992-11-23 | 1994-06-09 | Mark G. Palermo | Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds |
US5889006A (en) | 1995-02-23 | 1999-03-30 | Schering Corporation | Muscarinic antagonists |
IL117149A0 (en) | 1995-02-23 | 1996-06-18 | Schering Corp | Muscarinic antagonists |
WO1997012870A1 (en) | 1995-09-29 | 1997-04-10 | Glaxo Wellcome S.P.A. | Tetrahydroquinolines as nmda antagonists |
IL126003A0 (en) | 1996-04-10 | 1999-04-11 | Hoechst Marion Roussel Inc | Spiro [cyclopent [b] indole-piperidines] and n-[phenyl-hydrazon intermediates for their preparation both being acetyl cholinesterase and mao inhibitors |
DK0892796T3 (da) | 1996-04-12 | 2001-11-19 | Aventis Pharma Inc | Isatinderivater som acetylcholinesteraseinhibitorer og analgetika |
DE69715865T2 (de) | 1996-07-01 | 2003-08-07 | Schering Corp | Muscarin-antagonisten |
PL331536A1 (en) | 1996-08-15 | 1999-07-19 | Schering Corp | Muscarinic antagonists with an etheric bond |
EP0929521B1 (en) | 1996-09-30 | 2005-11-09 | Aventis Pharmaceuticals Inc. | Nmda (n-methyl-d-aspartate) antagonists |
KR100639543B1 (ko) | 1998-09-30 | 2006-10-31 | 다케다 야쿠힌 고교 가부시키가이샤 | 방광 배출력 개선제 |
DK1362844T3 (da) | 2001-01-26 | 2008-04-14 | Btg Int Ltd | Benzylaminanalog |
AU2002250256B2 (en) | 2001-03-08 | 2008-04-03 | Emory University | pH-dependent NMDA receptor antagonists |
WO2002080928A1 (en) | 2001-04-03 | 2002-10-17 | Merck & Co., Inc. | N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists |
IL159393A (en) | 2001-07-24 | 2011-01-31 | Richter Gedeon Vegyeszet | Piperidine derivatives, pharmaceutical compositions containing them, processes for their preparation and uses thereof |
SI1648882T1 (sl) | 2003-06-04 | 2009-02-28 | Merck & Co Inc | 3-fluoro-piperidini kot nmda/nr2b antagonisti |
GB0316094D0 (en) | 2003-07-09 | 2003-08-13 | Neuropharma Sa | Acetylcholinesterase dual inhibitors |
PT1729821E (pt) * | 2004-03-03 | 2013-10-23 | Revance Therapeutics Inc | Composições e métodos para aplicação tópica e administração transdérmica de toxinas botulínicas |
HU227119B1 (en) | 2004-07-29 | 2010-07-28 | Richter Gedeon Nyrt | Indole and benzimidazole carboxylic acid amide derivatives and pharmaceutical compositions containing them |
HUP0401523A3 (en) | 2004-07-29 | 2007-05-02 | Richter Gedeon Vegyeszet | Indole-2-carboxamide derivatives, pharmaceutical compositions containing them and process for producing them |
HU227000B1 (en) | 2004-07-29 | 2010-04-28 | Richter Gedeon Nyrt | Nmda receptor antagonist benzoyl urea derivatives, and pharmaceutical compositions containing them |
HU226977B1 (en) | 2004-07-29 | 2010-04-28 | Richter Gedeon Nyrt | Kynurenic acid amide derivatives, pharmaceutical compositions containing them and process for producing them |
HUP0401522A2 (en) | 2004-07-29 | 2006-04-28 | Richter Gedeon Vegyeszet | New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation |
TW200621677A (en) | 2004-09-21 | 2006-07-01 | Astellas Pharma Inc | Cyclic amine derivative or salt thereof |
EP1809604A1 (en) | 2004-10-15 | 2007-07-25 | Universidade Federal Do Rio De Janeiro - UFRJ | Piperidinic derivatives, pharmaceutic compositions containing the same and preparation processes |
DK1856114T3 (en) * | 2005-02-25 | 2014-11-17 | Raqualia Pharma Inc | Benzisoxazol-DERIVATIVES |
US20090124600A1 (en) | 2005-04-19 | 2009-05-14 | Layton Mark E | N-Alkyl-Azacycloalkyl NMDA/NR2B Antagonists |
JP2009503520A (ja) | 2005-07-29 | 2009-01-29 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | ベータアミロイド受容体及びその使用 |
JP2009531323A (ja) | 2006-03-20 | 2009-09-03 | カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ | アセチルコリンエステラーゼ阻害剤として有用な薬剤組成物 |
ES2288406B1 (es) | 2006-04-20 | 2008-12-16 | Universidad De Barcelona | Compuestos inhibidores de acetilcolinesterasa para el tratamiento de la enfermedad de alzheimer. |
AU2007336219A1 (en) | 2006-12-20 | 2008-06-26 | Solvay Pharmaceuticals B.V. | Compounds with a combination of cannabinoid-CB1 antagonism and acetylcholinesterase inhibition |
US7605265B2 (en) | 2007-01-22 | 2009-10-20 | Biotechnology Research Corporation Ltd. | Heterodimers and methods of using them |
AU2008247818B2 (en) | 2007-05-01 | 2011-10-20 | Sun Pharmaceutical Industries, Inc. | Morphinan compounds |
WO2008138200A1 (en) | 2007-05-11 | 2008-11-20 | Hong Kong University Of Science & Technology | Nmda and mc receptor antagonists exhibiting neuroprotective and memory enhancing activities |
MX2009014216A (es) | 2007-06-29 | 2010-07-05 | Univ Emory | Antagonistas del receptor nmda para neuroproteccion. |
WO2009036235A2 (en) | 2007-09-12 | 2009-03-19 | Virginia Tech Intellectual Properties, Inc. | Insecticidal carbamates exhibiting species-selective inhibition of acetylcholinesterase (ache) |
CN102066345B (zh) | 2008-01-16 | 2013-07-17 | 生物科技研究有限公司 | *唑烷衍生物作为nmda拮抗剂 |
EA014100B1 (ru) | 2008-02-21 | 2010-08-30 | Общество С Ограниченной Ответственностью "Валексфарм" | Производные 2,4-диаминопиридина, фармацевтическая композиция, лекарственное средство на их основе для лечения или предупреждения заболеваний и нарушений, вызванных гиперактивацией nmda-рецепторов и/или в качестве стимуляторов когнитивных функций и способ лечения |
CN101440061B (zh) | 2008-04-08 | 2010-12-08 | 温州医学院 | 一类具有抑制乙酰胆碱酯酶活性的芳基吡啶酮类衍生物 |
WO2009129181A1 (en) | 2008-04-14 | 2009-10-22 | Concert Pharmaceuticals Inc. | Propanediol-dicarbamate derivatives |
CA2722776A1 (en) | 2008-05-09 | 2009-11-12 | Emory University | Nmda receptor antagonists for the treatment of neuropsychiatric disorders |
-
2011
- 2011-02-09 CN CN2011800099647A patent/CN102762554A/zh active Pending
- 2011-02-09 CA CA2788656A patent/CA2788656A1/en not_active Abandoned
- 2011-02-09 EP EP11710564A patent/EP2536713A1/en not_active Withdrawn
- 2011-02-09 WO PCT/IB2011/050548 patent/WO2011101774A1/en active Application Filing
- 2011-02-09 MX MX2012008721A patent/MX2012008721A/es not_active Application Discontinuation
- 2011-02-09 JP JP2012553423A patent/JP2013519722A/ja not_active Withdrawn
- 2011-02-09 IN IN6631DEN2012 patent/IN2012DN06631A/en unknown
- 2011-02-09 SG SG2012053906A patent/SG183111A1/en unknown
- 2011-02-09 KR KR1020127021310A patent/KR20120123089A/ko not_active Application Discontinuation
- 2011-02-09 AU AU2011216950A patent/AU2011216950A1/en not_active Abandoned
- 2011-02-14 AR ARP110100443A patent/AR080172A1/es not_active Application Discontinuation
- 2011-02-14 UY UY0001033225A patent/UY33225A/es not_active Application Discontinuation
- 2011-02-15 TW TW100104942A patent/TW201141856A/zh unknown
- 2011-02-16 US US13/028,368 patent/US20120041026A1/en not_active Abandoned
-
2012
- 2012-08-28 ZA ZA2012/06469A patent/ZA201206469B/en unknown
Also Published As
Publication number | Publication date |
---|---|
TW201141856A (en) | 2011-12-01 |
SG183111A1 (en) | 2012-09-27 |
US20120041026A1 (en) | 2012-02-16 |
KR20120123089A (ko) | 2012-11-07 |
AU2011216950A1 (en) | 2012-08-23 |
JP2013519722A (ja) | 2013-05-30 |
AR080172A1 (es) | 2012-03-21 |
CA2788656A1 (en) | 2011-08-25 |
WO2011101774A1 (en) | 2011-08-25 |
UY33225A (es) | 2011-09-30 |
CN102762554A (zh) | 2012-10-31 |
EP2536713A1 (en) | 2012-12-26 |
MX2012008721A (es) | 2012-08-17 |
ZA201206469B (en) | 2013-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN06631A (zh) | ||
HK1139930A1 (en) | Cyclopamine lactam analogs and methods of use thereof | |
MX2009009428A (es) | Analogos de ciclopamina heterociclicos y metodos de uso de los mismos. | |
BR112012031620A2 (pt) | atm acessível para deficiente físico | |
SG176656A1 (en) | Microorganisms for the production of 1,4-butanediol and related methods | |
UA98312C2 (en) | Progesterone receptor antagonists | |
UA102065C2 (en) | Substituted 4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof | |
CO6551692A2 (es) | Nebulizador | |
GB201118864D0 (en) | Screen capture | |
EP3822352A3 (en) | Methods and compositions for modulating apolipoprotein(a) expression | |
MX362362B (es) | Pilar dental para el soporte de protesis dentales y metodo de fabricacion del mismo. | |
NZ603625A (en) | A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate | |
MX341306B (es) | Compuestos capaces de liberar compuestos fragantes. | |
AU2011305525A8 (en) | Modulators of the GPR119 receptor and the treatment of disorders related thereto | |
MY185134A (en) | 6-substituted phenoxychroman carboxylic acis derivatives | |
MX2010010345A (es) | Composiciones oftalmicas topicas mejoradas. | |
WO2011069095A3 (en) | Stuttering reduction method and device | |
MY156946A (en) | Composition for decreasing hardness of water | |
AU335069S (en) | Integrated winchhead | |
EP2580229A4 (en) | D5 desaturase-defective mutant gene and use thereof | |
IN2014CN00817A (zh) | ||
TWM385327U (en) | Automatic body temperature measuring device and equipment | |
IN2014CN00834A (zh) | ||
WO2009120381A3 (en) | Faucet system and advertising method | |
IN2014DN02984A (zh) |